News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
74,811 Results
Type
Article (5071)
Company Profile (19)
Press Release (69721)
Section
Business (23251)
Career Advice (143)
Deals (2933)
Drug Delivery (6)
Drug Development (8037)
Employer Resources (4)
FDA (1433)
Job Trends (1393)
News (35476)
Policy (2462)
Tag
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (4)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Standard (1)
Academia (539)
Academic (1)
Allergies (4)
Alliances (7790)
ALS (6)
Alzheimer's disease (174)
Antibody-drug conjugate (ADC) (6)
Approvals (1433)
Artificial intelligence (48)
Autoimmune disease (2)
Automation (1)
Bankruptcy (17)
Best Places to Work (1134)
Biosimilars (1)
Biotechnology (14)
Bladder cancer (9)
Brain cancer (8)
Breast cancer (47)
Cancer (391)
Cardiovascular disease (10)
Career advice (126)
Career pathing (5)
CAR-T (9)
Cell therapy (29)
Cervical cancer (1)
Clinical research (5689)
Collaboration (128)
Compensation (5)
COVID-19 (407)
CRISPR (3)
C-suite (36)
Cystic fibrosis (8)
Data (265)
Denatured (1)
Depression (1)
Diabetes (15)
Diagnostics (2711)
Digital health (2)
Diversity (1)
Drug discovery (24)
Drug pricing (1)
Drug shortages (1)
Duchenne muscular dystrophy (3)
Earnings (5829)
Editorial (2)
Employer branding (2)
Employer resources (3)
Events (9904)
Executive appointments (82)
FDA (1527)
Featured Employer (8)
Frontotemporal dementia (1)
Funding (92)
Gene editing (12)
Generative AI (4)
Gene therapy (23)
GLP-1 (60)
Government (456)
Guidances (6)
Healthcare (1917)
Immunology and inflammation (12)
Indications (3)
Infectious disease (429)
Inflammatory bowel disease (14)
Influenza (12)
Intellectual property (10)
Interviews (17)
IPO (1141)
IRA (1)
Job creations (293)
Job search strategy (115)
Kidney cancer (2)
Layoffs (19)
Leadership (1)
Legal (319)
Liver cancer (10)
Lung cancer (63)
Lymphoma (20)
Machine learning (1)
Management (1)
Manufacturing (14)
MASH (4)
Medical device (791)
Medtech (791)
Mergers & acquisitions (1833)
Metabolic disorders (41)
Multiple sclerosis (6)
Neurodegenerative disease (7)
Neuroscience (215)
NextGen: Class of 2025 (524)
Non-profit (513)
Northern California (301)
Now hiring (5)
Obesity (22)
Opinion (23)
Ovarian cancer (7)
Pain (8)
Pancreatic cancer (12)
Parkinson's disease (12)
Partnered (2)
Patents (18)
Patient recruitment (8)
Peanut (2)
People (8435)
Pharmaceutical (4)
Phase I (2382)
Phase II (2631)
Phase III (1513)
Pipeline (129)
Podcasts (4)
Policy (5)
Postmarket research (123)
Preclinical (1715)
Press Release (21)
Prostate cancer (16)
Psychedelics (1)
Radiopharmaceuticals (50)
Rare diseases (25)
Real estate (672)
Recruiting (1)
Regulatory (1861)
Reports (7)
Research institute (637)
Resumes & cover letters (17)
RNA editing (1)
Schizophrenia (3)
Series A (16)
Series B (8)
Sickle cell disease (2)
Southern California (197)
Spinal muscular atrophy (21)
Sponsored (1)
Startups (588)
Supply chain (3)
The Weekly (3)
United States (2123)
Vaccines (37)
Venture capitalists (1)
Webinars (2)
Weight loss (10)
Women's health (3)
Worklife (1)
Date
Today (9)
Last 7 days (65)
Last 30 days (299)
Last 365 days (3812)
2025 (931)
2024 (3934)
2023 (4844)
2022 (6311)
2021 (6571)
2020 (6251)
2019 (4573)
2018 (3454)
2017 (3984)
2016 (3988)
2015 (4687)
2014 (3236)
2013 (2742)
2012 (2875)
2011 (3100)
2010 (2524)
Location
Africa (68)
Alabama (3)
Alaska (1)
Arizona (14)
Asia (4032)
Australia (752)
California (626)
Canada (154)
China (63)
Colorado (17)
Connecticut (21)
Delaware (17)
Europe (11120)
Florida (68)
Georgia (5)
Idaho (4)
Illinois (49)
India (5)
Indiana (24)
Japan (16)
Kansas (3)
Kentucky (1)
Maine (3)
Maryland (78)
Massachusetts (413)
Michigan (20)
Minnesota (42)
Missouri (12)
Montana (1)
Nevada (1)
New Hampshire (2)
New Jersey (129)
New Mexico (7)
New York (187)
North Carolina (69)
North Dakota (4)
Northern California (301)
Ohio (22)
Oklahoma (1)
Oregon (3)
Pennsylvania (96)
Rhode Island (3)
South America (90)
Southern California (197)
Tennessee (1)
Texas (115)
Utah (54)
Virginia (12)
Washington D.C. (5)
Washington State (56)
West Virginia (1)
Wisconsin (7)
74,811 Results for "molecular assemblies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
January 28, 2025
·
4 min read
Biotech Beach
Molecular Assemblies Launches Partner Program for Onsite Synthesis of Long, Pure, Accurate DNA
Molecular Assemblies, Inc., a pioneer and leader in the field of enzymatic DNA synthesis, announced the launch of its Partnering Program to license Molecular Assemblies’ Fully Enzymatic SynthesisTM technology for onsite synthesis.
May 7, 2024
·
4 min read
Collaboration
Lilly Hops On Hot Molecular Glue Train With $1.2B+ Magnet Deal
The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and Novartis.
February 28, 2025
·
2 min read
·
Tristan Manalac
Business
Molecular Assemblies Announces the Appointment of Two Industry Leaders to Its Commercial-Technology Advisory Board
Molecular Assemblies, Inc. today announced the addition of two industry leaders to its Commercial-Technology Advisory Board (CTAB), which includes experts in the commercialization of nucleic acid technologies and innovative life science product solutions.
February 13, 2024
·
5 min read
Drug Development
Molecular Glue Degraders at Inflection Point as Pharma Dives In
Novartis, Biogen, Takeda and Novo Nordisk are all betting on advances in the molecular glue degraders space, collectively investing billions in hopes of treating cancer, Alzheimer’s disease, cardiometabolic disease and more.
December 16, 2024
·
6 min read
·
Kate Goodwin
Press Releases
Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program
April 1, 2025
·
5 min read
Press Releases
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
March 20, 2025
·
8 min read
Earnings
Biogen Tops Wall Street Expectations for Leqembi, Inks Molecular Glue Deal
Biogen touted strong Q3 sales of its Alzheimer’s drug Leqembi a day after announcing a deal worth up to $1.45 billion with Neomorph to discover and develop molecular glue degraders.
October 30, 2024
·
2 min read
·
Heather McKenzie
Collaboration
Novartis Inks Potential $2.2B Molecular Glue Deal With Monte Rosa
The Swiss pharma is paying $150 million upfront to gain rights to Monte Rosa’s VAV1-targeting molecular glue degraders, led by a Phase I candidate which holds therapeutic promise for immune-mediated diseases.
October 28, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Revive Therapeutics Announces LOI to Acquire DiagnaMed’s Molecular Hydrogen Program
March 3, 2025
·
5 min read
1 of 7,482
Next
